Malformations) is underway to look at this issue. In the current study, we present the outcomes of radiosurgical treatment of unruptured AVMs. We determine the postradiosurgical hemorrhage rate. We also evaluate the rate of success from this approach and the rate of procedurerelated morbidity. Finally, we determine factors related to successful obliteration, latency-period hemorrhage, and postradiosurgical complications.
Methods

Patient Population
We reviewed a prospective database approved by our institutional review board including a total of 1204 patients with AVMs who were treated with Gamma Knife surgery at the University of Virginia between 1989 and 2009. We identified 522 patients who had unruptured cerebral AVMs at the time of treatment. All patients with less than 2 years of imaging follow-up were excluded, with the exception of patients who demonstrated radiological evidence of total obliteration on either MRI or DSA. We only included patients with a minimum of 2 years' follow-up because it is well known and widely accepted that at least 2 years is typically required for obliteration of AVMs. This left 406 patients who had a minimum of 2 years of imaging and clinical follow-up (mean [± SD] 81 ± 48 months or 6.7 ± 4.0 years, median 69 months [IQR 39-116 months] or 5.7 years [IQR 3.3-9.7 years], and range 24-284 months or 2.0-23.7 years). Additionally, there were 38 patients with less than 2 years of imaging followup in whom MRI or DSA demonstrated obliteration-on MRI in 14 cases and on DSA in 24, with a mean imaging follow-up of 18 months (SD 5 months) or 1.5 years (SD 0.4 years), median 20 months (IQR 16-22 months) or 1.7 years (IQR 1.3-1.8 years), and range 8-24 months (0.6-2.0 years)-for a total of 444 patients included in our analyses (Fig. 1) .
The characteristics of the patients and their AVMs prior to radiosurgery are summarized in Table 1 . There were 49 pediatric patients (11.0%), less than 18 years old, and 395 adult patients (89.0%). The most common presenting symptoms were seizure (occurring in 208 patients [46.8%]), headache (123 patients [27 .7%]), and focal neurological deficit (53 patients [11.9%] ). The SpetzlerMartin grade, which takes into account AVM diameter, presence of deep draining veins, and location in eloquent brain, 28 was I in 81 patients (18.2%), II in 167 (37.6%), III in 163 (36.7%), IV in 30 (6.8%), and V in 3 (0.7%). We also calculated the modified Pittsburgh radiosurgerybased AVM score, which accounts for patient age, deep location, and AVM volume. 36 
Radiosurgery
The radiosurgical technique for patients with AVMs at our center has been previously described. 33 In brief, under monitored anesthesia for adults and general anesthetic for pediatric patients, a Leksell G-frame was affixed to the patient's head with 4 pins. The patient was then taken to the neurointerventional suite where DSA was performed. An MRI was also obtained. Using a combination of DSA and MRI, the nidus was delineated and treated with radiosurgery. The mean nidus volume was 4.2 ± 3.6 cm 3 (range 0.1-29.4 cm 3 ), the median margin dose (dose to the edge of the AVM nidus) was 20 Gy (IQR 18-23 Gy,  range 5-30 Gy), the median maximum dose was 40 Gy  (IQR 26-36 Gy, range 10 .0-55.6 Gy), the median number of isocenters was 2 (IQR 2-3, range , and the median isodose was 50% (IQR 50%-50%, range 30%-90%). A total of 64 patients (14.4%) with residual AVMs 3 years after their initial radiosurgery procedures received repeat radiosurgery; 3 patients had 2 repeat treatments and 61 had 1 repeat treatment.
Radiological and Clinical Follow-Up
Following radiosurgery, patients underwent MRI every 6 months for 2 years and then annually after that. The MRI and DSA studies were performed at a combination of facilities including those at the University of Virginia, outside hospitals, and outpatient centers. All imaging studies were reviewed by an attending neurosurgeon and attending neuroradiologist at the University of Virginia. The overall mean duration of imaging follow-up was 76 ± 49 months or 6. confidence interval, and p value for each factor were reported. A p value less than 0.05 indicated a statistically significant hazard ratio as did a 95% CI not including 1.0. If more than one variable had a statistically significant hazard ratio, a multivariate Cox regression analysis was employed to determine the independent effects of the univariate significant variables. Kaplan-Meier plot was used to calculate time to obliteration. For hemorrhage risk, the number of risk years was defined as the total time across all patients from radiosurgery to either obliteration or to last imaging follow-up in patients without obliteration.
Results
AVM Obliteration and Factors Predicting Obliteration After Radiosurgery
Overall, 70 patients (15.8%) had obliteration diagnosed by MRI only and 205 patients (46.2%) had obliteration diagnosed by DSA, for a cumulative obliteration rate of 62%. The postradiosurgery actuarial rate of obliteration was 30% at 3 years, and 53% at 5 years. The actuarial obliteration rate in patients without postradiosurgery hemorrhage, 31% at 3 years and 54% at 5 years, was significantly higher than in patients with postradiosurgery hemorrhage, 24% at 3 years and 36% at 5 years (p = 0.018). Figure 3 shows the rate of AVM obliteration over time following radiosurgery. Figure 4 compares the obliteration rate over time for patients with and without postradiosurgery hemorrhage. Table 2 shows the results of univariate and multivariate Cox regression analysis for various patient, AVM, and treatment characteristics and their effects on obliteration rate. Regarding postradiosurgery obliteration, absence of preradiosurgery embolization, decreased AVM volume, increased margin dose, superficial venous drainage, single draining vein, radiographic presence of RIC, lower Pittsburgh radiosurgerybased AVM score, and lower Spetzler-Martin grade were found to be statistically significant in the univariate analysis. In the multivariate analysis, no preradiosurgery embolization, increased margin dose, single draining vein, radiological presence of RIC, and lower Spetzler-Martin grade were found to be significant independent positive predictors.
Postradiosurgery Hemorrhage Rate and Factors Predicting Hemorrhage
There were 35 postradiosurgery hemorrhages (29 patients had 1 hemorrhage and 3 had 2 hemorrhages) over 2132 risk years, resulting in an annual hemorrhage risk of 1.6%. Table 3 shows the results of univariate and multivariate Cox regression analysis for multiple factors and their effects on postradiosurgery hemorrhage. The statistically significant positive predictors of hemorrhage in the univariate analysis were increased AVM volume and higher radiosurgery-based AVM score. The multivariate analysis did not demonstrate any independent predictors of postradiosurgery hemorrhage. Of note, no patient with radiologically confirmed obliteration on MRI or DSA had subsequent hemorrhage.
Radiation-Induced Changes, Postradiosurgery Cyst Formation, and Radiation-Induced Neoplasia
Radiation-induced changes were detected on T2-weighted MRI in 216 patients (48.6%) at a mean of 13 ± 11 months after radiosurgery (median 9 months [IQR 6-14 months], range 0-87 months). However, only 61 pa- tients (13.7%) were symptomatic as a result of RIC. Symptoms included focal neurological deficits in 35 patients (7.9%), headaches in 18 patients (4.1%), and seizures in 13 patients (2.9%). Five patients (1.1%) had more than one of the aforementioned RIC-related symptoms. Radiationinduced changes resulted in permanent symptoms in 9 patients (2.0%). Postradiosurgery cyst formation was seen Tables 4 and 5 show the results of univariate Cox regression analyses for the effects of multiple variables on RIC and postradiosurgery cyst formation, respectively. Multivariate analysis was performed for neither RIC nor postradiosurgery cyst formation because there was no more than one statistically significant variable in either univariate analysis. There were no statistically significant predictors of RIC, although deep location approached statistical significance (p = 0.052). The presence of RIC was a statistically significant positive predictor of postradiosurgery cyst formation. In this series, we observed no development of a radiation-induced malignancy following radiosurgery.
Clinical Outcomes Following Radiosurgery
At last clinical follow-up after radiosurgery, 32 patients (7.2%) were neurologically improved, 30 patients were neurologically worsened (6.8%), and 382 patients were neurologically unchanged (86.0%) compared with initial presentation. New-onset seizures developed in 4 patients (0.9%) following radiosurgery. Of the group of 208 patients who initially presented with seizures, 105 patients (50.5%) had decreased seizure frequency (including 16 patients [7. 7%] who were seizure-free), 10 patients (2.3%) had increased seizure frequency, and 93 patients (44.7%) had unchanged seizure frequency. Of the 32 patients with postradiosurgery hemorrhage, 6 patients (18.8%) experienced clinical deterioration compared with 24 (5.8%) of 411 patients without postradiosurgery hemorrhage who experienced clinical deterioration. By chi-square test, the incidence of clinical deterioration was significantly higher in patients with postradiosurgery hemorrhage than in patients without postradiosurgery hemorrhage (p = 0.018).
Discussion
The management of unruptured AVMs is controversial. While some experts recommend therapeutic intervention, others do not. 7, 31 Several studies suggest that the natural history of unruptured AVMs is more benign than that of ruptured AVMs. 8, 21, 30 Such controversy has led to initiation of the ARUBA trial, which represents an attempt to evaluate the difference in outcome between no treatment and best available treatment of patients with unruptured AVMs. Although unruptured AVMs seem to have a more favorable natural history, the hemorrhage risk is not negligible and, depending on the lesion size and location, the morbidity associated with hemorrhage may not be inconsequential. In a group of 168 patients with untreated, unruptured AVMs, Brown et al. 4 reported an annual hemorrhage rate of 2.2%.
Radiosurgery offers a minimally invasive method of achieving AVM obliteration, although there has yet to be definitive evidence that the outcomes of treatment, taking into consideration the postradiosurgical complications and hemorrhage during the latency period, are superior to conservative management. From our 20-year institutional experience, radiosurgical treatment of unruptured AVMs seems to provide a favorable risk-benefit profile with a reasonably low postradiosurgery hemorrhage rate (1.6%) and a low risk of permanent neurological deficits associated with radiosurgery (2.0%). Additionally, a high percentage of nonhemorrhage-related symptoms resolved after radiosurgery. 33 The goal of treating AVMs with radiosurgery is to reduce and ultimately, with obliteration, eliminate the future hemorrhage risk. Mechanisms of AVM obliteration following radiosurgery include progressive intimal thickening, thrombosis of irradiated vessels, and eventual occlusion of vascular lumen. 6, 26 We have identified factors that correlate with obliteration, postradiosurgery hemorrhage, and postradiosurgery cyst formation. Our study has an inherent selection bias associated with only including patients with at least 2 years of radiographic follow-up. However, most postradiosurgery complications do not occur until 18 months after treatment or later, and the vast majority of AVMs treated with radiosurgery are not obliterated before 2 years after treatment.
Embolization has previously been reported to decrease the radiosurgical obliteration rate of AVMs. 2, 22, 25 While it stands to reason that AVMs that require preradiosurgery embolization are, on average, larger than those not requiring embolization, our multivariate analysis demonstrated that embolization was an independent negative predictor of obliteration (p < 0.001). The decision to partially embolize an AVM prior to treatment with radiosurgery arises when an AVM is too large-typically greater than 3 cm in maximum diameter or greater than 15 cm 3 in volume-to treat with radiosurgery alone. Therefore, we rely on embolization to reduce the AVM to a targetable size. 27 In these cases, we do not irradiate the embolized portion of the AVM, instead focusing on the remainder of the nidus. Unfortunately, embolization does not guarantee flow cessation, as previously treated arterial feeding vessels have been known to become recanalized. 24 Embolization can make radiosurgical planning more difficult if it fails to target a specific sector of the nidus, potentially transforming a compact nidus into a diffuse one. It has also been proposed, although not proven, that certain embolization materials, such as Onyx, either scatter or absorb radiation, thereby altering the dose actually delivered to the nidus. 2 Additionally, we must keep in mind that AVM embolization carries its own set of complications, including microcatheter entrapment in cyanoacrylate glue or Onyx, arterial perforation with the microcatheter, AVM hemorrhage due to premature draining vein occlusion, and stroke secondary to reflux of embolic agents into unintended vessels. The combined morbidity and mortality rate from embolization complications is not trivial, exceeding 10% in some studies. 19, 34 In the cases in our study, the AVM nidus was treated with a median margin dose of 20 Gy and the median maximum delivered dose was 40 Gy. Not surprisingly, increased margin dose resulted in increased obliteration (p < 0.001). Almost half of the patients showed imaging evidence of postradiosurgery RIC which also independently correlated with obliteration (p = 0.004). However, the potential benefit of increasing the radiation dose must be weighed against the increased morbidity that comes with it. 10, 17 In our study, we saw a 13.7% rate of symptomatic RIC and a 2.3% rate of posttreatment cyst formation, and we found RIC to be a predictor of cyst formation in univariate analysis (p = 0.032). Flickinger et al. 9 demonstrated an increasing rate of permanent radiosurgeryinduced deficits as the volume of tissue receiving 12 Gy increased. The same group reported a lower rate of postradiosurgery RIC but comparable rates of symptomatic RIC. 10 In our univariate analysis, the correlation between deep AVM location and RIC approached significance (p = 0.052). We otherwise did not identify any significant predictors of RIC.
The presence of a single draining vein was found to be independently correlated with obliteration (p < 0.001). An AVM with multiple draining veins will have more complex angioarchitecture and is more likely to have a diffuse nidus than an AVM with a single draining vein. Diffuse AVMs may be difficult to target during treatment planning and may require preradiosurgery embolization and/or staged radiosurgery to be treated successfully. Although Spetzler-Martin grade was originally developed to predict postoperative morbidity following microsurgical AVM resection, its use as a common way to describe AVMs has become widespread. 28 Lower Spetzler-Martin grade was shown to correlate with obliteration (p = 0.016) on multivariate analysis in our study, while the factors that comprise the grading system were not. This suggests that the way in which the Spetzler-Martin grade weighs each AVM characteristic is important for radiosurgical outcomes too.
Finally, we consider whether unruptured AVMs should be treated at all. Generally, the risks associated with stereotactic radiosurgery were temporary; those risks that were permanent were typically not debilitating for the patient. In our series, there was a 6.8% postradiosurgery morbidity rate, one-third of which involved increased seizure frequency. Additionally, those patients who had postradiosurgery hemorrhage were more likely to deteriorate clinically (p = 0.018). We report a 1.6% annual hemorrhage risk after radiosurgery for patients with previously unruptured AVMs. This is comparable to or slightly lower than the traditionally quoted annual hemorrhage risk of 2%-4%. 4, 11, 20 However, studies that have stratified AVMs into risk groups based on various AVM characteristics have shown that those AVMs with low risk factors-such as superficial location, compact nidus, superficial venous drainage, fewer draining veins, and no history of hemorrhage-have annual hemorrhage rates of approximately 1%. 21, 30 A randomized trial of unruptured brain AVMs (ARUBA), funded by the National Institute of Neurological Disorders, is currently underway to compare interventional outcomes with natural history. 18 We acknowledge that information about the response of symptoms such as headaches and focal neurological deficits following radiosurgery for unruptured AVMs would be useful to patients and physicians. Unfortunately, we do not have readily available, reliable, and objective assessments of headache response in patients. Moreover, the heterogeneity of neurological deficits as well as the small resulting subgroups for focal neurological deficits would preclude any meaningful statistical analysis of symptomatic response in this single-institution series of patients.
We hope that such data will be forthcoming in prospective trials like the ARUBA study. Based upon our experience, we recommend treating patients with unruptured AVMs if they are younger and therefore have more at-risk years for hemorrhage, have a larger-volume AVM, and a higher radiosurgery-based AVM grade. Although the risks from radiosurgery are not inconsequential, the long-term hemorrhage risk of an AVM, even if unruptured at the time of presentation, and the morbidity and mortality associated with an AVM hemorrhage make radiosurgery a reasonable treatment option for some patients with unruptured AVMs.
Conclusions
Radiosurgery offers a reasonable benefit-to-risk profile for patients with unruptured AVMs. Until the AVMs were obliterated, the cohort of patients with unruptured AVMs demonstrated an annual hemorrhage rate comparable to traditionally quoted figures.
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